Pleuritis, also known as pleurisy, is inflammation of the pleura—the thin membranes surrounding the lungs and lining the chest cavity. This condition causes sharp, stabbing chest pain that worsens with breathing, coughing, or sneezing, often accompanied by shortness of breath, cough, fever, or fluid buildup (pleural effusion). Common causes include viral or bacterial infections (e.g., pneumonia, tuberculosis), autoimmune disorders (e.g., lupus, rheumatoid arthritis), pulmonary embolism, or chest trauma. Diagnosis typically involves imaging (chest X-rays, CT scans, ultrasound), blood tests, and sometimes thoracentesis to analyze pleural fluid. Treatment targets the underlying cause with antibiotics for bacterial infections, antifungals, blood thinners, or nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation relief. Advanced cases may require corticosteroids or procedures to drain fluid.

Market Overview

According to Data Bridge Market Research, the global pleuritis market was valued at USD 2.10 billion in 2024 and is projected to reach USD 3.03 billion by 2032, growing at a CAGR of 4.70% during the forecast period of 2025–2032. This steady growth is supported by rising respiratory infections, autoimmune disease prevalence, and advancements in non-invasive diagnostics like AI-assisted imaging.

Market Segmentation

The market is segmented as follows:

• By Diagnostic Type → Imaging Devices (largest share due to tools like X-rays and CT), Thoracentesis (fastest-growing for fluid analysis), Blood Test, Others.
• By Treatment Type → Antibiotics (leading for bacterial cases), NSAIDs (fastest-growing for symptom relief), Antifungals, Blood Thinners, Others.
• By End User → Hospitals (dominant for comprehensive care), Clinics, Diagnostic Laboratories (fastest-growing), Others.
• By Mode of Purchase → Prescription (majority share), Over the Counter (growing for NSAIDs).
• By Distribution Channel → Hospital Pharmacies (leading), Retail Pharmacies, Online Pharmacies (fastest-growing).

Key Market Drivers

• Increasing respiratory infections and autoimmune conditions driving diagnostic and therapeutic demand.
• Advancements in imaging technologies, including AI for precise pleural effusion detection.
• Growing elderly population and awareness of early intervention.

Restraints and Challenges

• Limited access to advanced diagnostics in low-income regions.
• High treatment costs and regulatory hurdles for new therapies.
  
  Get the full report:
  https://www.databridgemarketresearch.com/reports/global-pleuritis-market

Opportunities

• Development of AI-integrated tools and point-of-care testing.
• Expansion in biologics and targeted anti-inflammatory treatments.

Regional Insights

• North America dominates with over 41% share, led by the U.S., due to advanced infrastructure and high adoption of innovative diagnostics.
• Asia-Pacific is the fastest-growing, driven by tuberculosis prevalence and healthcare investments in India and China.

Major Market Players

Key companies include Scanlan International, Olympus Corporation, Wexler Surgical, Sontec Instruments, Inc., Integra LifeSciences Corporation, Delacroix-Chevalier, Boston Medical Products, Inc., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Merck & Co., Inc., GSK plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, BD, and others. These focus on imaging innovations and respiratory therapies.

Conclusion

The Global pleuritis market is advancing steadily through 2032, supported by diagnostic improvements and infection management needs. North America leads, with Asia-Pacific emerging rapidly. Innovations in AI and rapid testing will address access gaps, enhancing outcomes for pleural inflammatory conditions.

This summary is based on publicly available insights from the Data Bridge Market Research report overview as of late 2025. For detailed quantitative forecasts, financials, and custom analysis, refer to the full report at the original source.

Browse More Reports:

U.S. Stoma/Ostomy Care Market
West Africa Dairy Protein Ingredients Market
Saudi Arabian Functional Mushroom Market
North America Kids E Scooter Market
GCC Fine Fragrances Market
Europe Phytogenic Feed Additives Market
Asia-Pacific Phytogenic Feed Additives Market
Middle East and Africa Phytogenic Feed Additives Market
North America Phytogenic Feed Additives Market
North America Floor Adhesive Market
Europe Fine Fragrances Market
Europe Hepatitis Delta Virus (HDV) Infection Market
Middle East and Africa Hepatitis Delta Virus (HDV) Infection Market
North America Hepatitis Delta Virus (HDV) Infection Market
Europe Mass Spectrometry Market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com